Novartis AG (NVS) Q3 2017 Earnings Results

Novartis AG ADR Misses on EPS, Stock Down 3.24%

The earnings report indicates that Novartis AG ADR's performance was below expectations for EPS, contributing to a 3.24% decline in stock price. Investors may be concerned about the lack of revenue details and guidance, which could signal uncertainty in future performance. The cautious tone from management suggests they are aware of market challenges but are focusing on long-term strategies.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.88	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed a cautious outlook, highlighting ongoing product development efforts. They acknowledged market challenges but remain committed to their long-term strategy.

Management emphasized the importance of ongoing product development.

They acknowledged challenges in the market but remain focused on strategic goals.

Novartis AG ADR Misses on EPS, Stock Down 3.24%

Key numbers

Management commentary

Novartis AG

More earnings this week

Novartis AG ADR Misses on EPS, Stock Down 3.24%

Key numbers

Management commentary